FOOTHILL RANCH, Calif.,
Nov. 13, 2020 /PRNewswire/
-- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in
dental lasers, today announced it has been invited to
participate in the Benchmark Company Discovery One on One Investor
Conference on November 18, 2020.
President and CEO Todd Norbe and
Executive Vice President, CFO and COO John
Beaver will hold virtual meetings with institutional
investors throughout the day.
For additional information or to schedule a virtual meeting
with BIOLASE, please contact your Benchmark representative, or the
EVC Group, LLC, BIOLASE's investor relations firm.
About BIOLASE, Inc.
BIOLASE is a medical device company that develops, manufactures,
markets, and sells laser systems in dentistry and
medicine. BIOLASE's products advance the practice of dentistry
and medicine for patients and healthcare
professionals. BIOLASE's proprietary laser products
incorporate approximately 259 patented and 41 patent-pending
technologies designed to provide biologically and clinically
superior performance with less pain and faster recovery
times. BIOLASE's innovative products provide
cutting-edge technology at competitive prices to deliver superior
results for dentists and patients. BIOLASE's principal
products are revolutionary dental laser systems that perform a
broad range of dental procedures, including cosmetic and complex
surgical applications. BIOLASE has sold over 41,500 laser
systems to date in over 80 countries around the world. Laser
products under development address BIOLASE's core dental
market and other adjacent medical and consumer applications.
For updates and information on Waterlase iPlus®, Waterlase
Express™, and laser dentistry, find BIOLASE online
at www.biolase.com, Facebook at www.facebook.com/biolase,
Twitter at www.twitter.com/biolaseinc, Instagram
at www.instagram.com/waterlase_laserdentistry, and LinkedIn
at www.linkedin.com/company/biolase.
BIOLASE®, Waterlase® and Waterlase iPlus® are registered
trademarks of BIOLASE, Inc.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/biolase-to-participate-at-the-benchmark-company-discovery-one-on-one-investor-conference-on-november-18-2020-301172969.html
SOURCE BIOLASE, Inc.